Cargando…
Progress in Nanocarriers Codelivery System to Enhance the Anticancer Effect of Photodynamic Therapy
Photodynamic therapy (PDT) is a promising anticancer noninvasive method and has great potential for clinical applications. Unfortunately, PDT still has many limitations, such as metastatic tumor at unknown sites, inadequate light delivery and a lack of sufficient oxygen. Recent studies have demonstr...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617654/ https://www.ncbi.nlm.nih.gov/pubmed/34834367 http://dx.doi.org/10.3390/pharmaceutics13111951 |
_version_ | 1784604557289979904 |
---|---|
author | Yang, Yu-Ling Lin, Ke Yang, Li |
author_facet | Yang, Yu-Ling Lin, Ke Yang, Li |
author_sort | Yang, Yu-Ling |
collection | PubMed |
description | Photodynamic therapy (PDT) is a promising anticancer noninvasive method and has great potential for clinical applications. Unfortunately, PDT still has many limitations, such as metastatic tumor at unknown sites, inadequate light delivery and a lack of sufficient oxygen. Recent studies have demonstrated that photodynamic therapy in combination with other therapies can enhance anticancer effects. The development of new nanomaterials provides a platform for the codelivery of two or more therapeutic drugs, which is a promising cancer treatment method. The use of multifunctional nanocarriers for the codelivery of two or more drugs can improve physical and chemical properties, increase tumor site aggregation, and enhance the antitumor effect through synergistic actions, which is worthy of further study. This review focuses on the latest research progress on the synergistic enhancement of PDT by simultaneous multidrug administration using codelivery nanocarriers. We introduce the design of codelivery nanocarriers and discuss the mechanism of PDT combined with other antitumor methods. The combination of PDT and chemotherapy, gene therapy, immunotherapy, photothermal therapy, hyperthermia, radiotherapy, sonodynamic therapy and even multidrug therapy are discussed to provide a comprehensive understanding. |
format | Online Article Text |
id | pubmed-8617654 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86176542021-11-27 Progress in Nanocarriers Codelivery System to Enhance the Anticancer Effect of Photodynamic Therapy Yang, Yu-Ling Lin, Ke Yang, Li Pharmaceutics Review Photodynamic therapy (PDT) is a promising anticancer noninvasive method and has great potential for clinical applications. Unfortunately, PDT still has many limitations, such as metastatic tumor at unknown sites, inadequate light delivery and a lack of sufficient oxygen. Recent studies have demonstrated that photodynamic therapy in combination with other therapies can enhance anticancer effects. The development of new nanomaterials provides a platform for the codelivery of two or more therapeutic drugs, which is a promising cancer treatment method. The use of multifunctional nanocarriers for the codelivery of two or more drugs can improve physical and chemical properties, increase tumor site aggregation, and enhance the antitumor effect through synergistic actions, which is worthy of further study. This review focuses on the latest research progress on the synergistic enhancement of PDT by simultaneous multidrug administration using codelivery nanocarriers. We introduce the design of codelivery nanocarriers and discuss the mechanism of PDT combined with other antitumor methods. The combination of PDT and chemotherapy, gene therapy, immunotherapy, photothermal therapy, hyperthermia, radiotherapy, sonodynamic therapy and even multidrug therapy are discussed to provide a comprehensive understanding. MDPI 2021-11-18 /pmc/articles/PMC8617654/ /pubmed/34834367 http://dx.doi.org/10.3390/pharmaceutics13111951 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Yang, Yu-Ling Lin, Ke Yang, Li Progress in Nanocarriers Codelivery System to Enhance the Anticancer Effect of Photodynamic Therapy |
title | Progress in Nanocarriers Codelivery System to Enhance the Anticancer Effect of Photodynamic Therapy |
title_full | Progress in Nanocarriers Codelivery System to Enhance the Anticancer Effect of Photodynamic Therapy |
title_fullStr | Progress in Nanocarriers Codelivery System to Enhance the Anticancer Effect of Photodynamic Therapy |
title_full_unstemmed | Progress in Nanocarriers Codelivery System to Enhance the Anticancer Effect of Photodynamic Therapy |
title_short | Progress in Nanocarriers Codelivery System to Enhance the Anticancer Effect of Photodynamic Therapy |
title_sort | progress in nanocarriers codelivery system to enhance the anticancer effect of photodynamic therapy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617654/ https://www.ncbi.nlm.nih.gov/pubmed/34834367 http://dx.doi.org/10.3390/pharmaceutics13111951 |
work_keys_str_mv | AT yangyuling progressinnanocarrierscodeliverysystemtoenhancetheanticancereffectofphotodynamictherapy AT linke progressinnanocarrierscodeliverysystemtoenhancetheanticancereffectofphotodynamictherapy AT yangli progressinnanocarrierscodeliverysystemtoenhancetheanticancereffectofphotodynamictherapy |